Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00811746 · ClinicalTrials.gov registry record · NA
Hypnotics to Improve Polysomnography Yield: Eszopiclone vs Ramelteon?
A NA study of Obstructive Sleep Apnea, sponsored by Southern California Institute for Research and Education.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT00811746: Completed NA study of Obstructive Sleep Apnea, sponsored by Southern California Institute for Research and Education.
NCT00811746 is a NA study of Obstructive Sleep Apnea that has completed, run by Southern California Institute for Research and Education. The registered enrollment target is 90 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00811746, a NA study of Obstructive Sleep Apnea, has completed, sponsored by Southern California Institute for Research and Education.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to determine if eszopiclone is as effective as ramelteon when used as a pre-medication (sleeping pill) in sleep studies performed to diagnose and treat sleep apnea.
Conditions Studied
Interventions
- DRUG Rozerem (Ramelteon)
- DRUG Lunesta (Eszopiclone)
- OTHER Historical Controls
Study Locations (1)
California
- VA Long Beach Healthcare System - Long Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-10 |
| Phase | NA |
What the finished NCT00811746 record still lists
NCT00811746 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 3 interventions - of which Rozerem (Ramelteon) is the first listed.
NCT00811746 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00811746 about?
NCT00811746 is a clinical study titled "Hypnotics to Improve Polysomnography Yield: Eszopiclone vs Ramelteon?". This study is being conducted to determine if eszopiclone is as effective as ramelteon when used as a pre-medication (sleeping pill) in sleep studies performed to diagnose and treat sleep apnea.
What is the current status of trial NCT00811746?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2008-12. Estimated completion is 2010-10.
What conditions does trial NCT00811746 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea.
What interventions are being tested in trial NCT00811746?
The interventions under investigation include: Rozerem (Ramelteon) (DRUG), Lunesta (Eszopiclone) (DRUG), Historical Controls (OTHER).
Who is sponsoring clinical trial NCT00811746?
This trial is sponsored by Southern California Institute for Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00811746 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00811746's enrollment target sits among peer trials
90 73rd of 155 higher than 82 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia